Your session is about to expire
← Back to Search
Procedure
Preventative Surgery for Contracture
N/A
Recruiting
Led By Sanjeev Kakar, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Failed non-operative treatment or elected surgical treatment
Clinical diagnosis of trigger finger with co-existing pretendinous cord
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 1 year
Awards & highlights
Study Summary
This trial is investigating a new surgical technique to help those with trigger finger and a pre-existing Dupuytren's cord minimize potential complications like scarring and discomfort after surgery.
Who is the study for?
This trial is for adults with trigger finger and a condition called Dupuytren's Contracture, who haven't had success with non-surgical treatments and have chosen to undergo surgery.Check my eligibility
What is being tested?
The study tests a surgical technique that removes or manipulates the pretendinous cord during trigger finger surgery, aiming to reduce scarring and improve recovery.See study design
What are the potential side effects?
Potential side effects may include discomfort, difficulty moving the affected fingers or hand, thickened scars at the surgery site, and other complications related to hand surgeries.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
Non-surgical treatments didn't work for me or I chose surgery.
Select...
I have been diagnosed with trigger finger and have a cord in my palm.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Scar Progression as measured by the Patient and Observer Scar Assessment Scale
Change in Scar Progression as measured by the Vancouver Scar Scale
Trial Design
2Treatment groups
Active Control
Group I: Division/manipulation of the cordActive Control1 Intervention
patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be incised.
Group II: Pretendinous cord excisionActive Control1 Intervention
Patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be excised
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,767,000 Total Patients Enrolled
Sanjeev Kakar, M.D.Principal InvestigatorMayo Clinic
Sanjeev Kakar, MDPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Non-surgical treatments didn't work for me or I chose surgery.I am under 18 years old.I have been diagnosed with trigger finger and have a cord in my palm.
Research Study Groups:
This trial has the following groups:- Group 1: Division/manipulation of the cord
- Group 2: Pretendinous cord excision
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger